共 42 条
[1]
Baier, M., Dittmar, M.T., Cichutek, K., Kurth, R., Development in vivo of genetic variability of SIV (1980) Proc. Natl. Acad. Sci. USA, 88, pp. 8126-8130
[2]
Balfe, P., Simmonds, P., Ludlam, C.A., Bishop, J.O., Leigh Brown, A.J., Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: Rate of sequence change and low frequency of inactivating mutations (1990) J. Virol., 64, pp. 6221-6233
[3]
Bangham, C.R.M., Human T-cell leukaemia virus type 1 and neurological disease (1993) Curr. Opin. Neurobiol., 3, pp. 773-778
[4]
Bonhoeffer, S., Nowak, M.A., Intra-host versus inter-host selection: Viral strategies of immune function impairment (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 8062-8066
[5]
Bonhoeffer, S., Nowak, M.A., Can live attenuated virus work as post-exposure treatment? (1995) Immunol. Today, 3, pp. 131-135
[6]
Borrow, P., Lewicki, H., Wei, X., Horwitz, M.S., Pfeffer, N., Meyers, H., Nelson, J.A., Shaw, G.M., Antiviral pressure exerted by HIV-1 specific CTLs during primary infection demonstrated by rapid selection of CTL escape virus (1997) Nature Med., 3, pp. 205-211
[7]
Burns, D.P.W., Desrosiers, R.C., Selection of genetic variants of SIV in persistently infected rhesus monkeys (1991) J. Virol., 65, pp. 1843-1854
[8]
Clements, J.E., Pedersen, F.S., Narayan, O., Haseltine, W.A., Genomic changes associated with antigenic variation of visna virus during persistent infection (1980) Proc. Natl. Acad. Sci. USA, 77, pp. 4454-4458
[9]
De Boer, R.J., Boerlijst, M.C., Diversity and virulence thresholds in AIDS (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 544-548
[10]
De Boer, R.J., Boucher, C.A.B., Anti-CD4 therapy for AIDS suggested by mathematical models (1996) Proc. Roy. Soc. London B, 263, pp. 899-905